Grafting health management services is an important part of Internet channel innovation in health insurance derivative services, but in fact, this kind of grafting is difficult to achieve due to the defects of the Internet sales model itself.
First of all, due to its functions and characteristics, Internet channels are mostly simple, intuitive, and relatively standardized products, such as fixed-income type of critical illness insurance, accident insurance, and travel insurance. This kind of product guarantees a certain kind of probabilistic event. The characteristic is that the contact with the user only appears when the probability event occurs. It is extremely low frequency, and there is no medical connection with the user. Pay-as-you-do insurance that truly has daily medical service data and long-term close contact with users requires professional consultant sales because of the complexity and individuality of its products, and is not suitable for Internet channels.
Under the background of simple products sold by the Internet, insurance companies simply do not have medical data of users. It is not known about their health status and risks. When users purchase such products, the purpose is only to obtain a low level. Probabilistic, but compensatory safeguards for devastating events are not intended to have daily interactions and medical contacts with insurance companies. Therefore, if an insurance company does not know the health status of its users and cannot obtain its treatment information and health needs, it is extremely blind and purposeless to graft health services on such products. The results will be extremely limited.
At the same time, another feature of the development of Internet health insurance is to try to use the Internet to screen out the characteristics of a certain type of user with special needs, such as diabetes patients, to graft specific insurance plans for certain types of patients, and to match this Health management of the disease to help users reduce the risk of disease progression. However, such products seem to cater to a type of user demand in terms of ensuring the matching of design and service, but in reality it does not meet the user's psychological and insurance nature.
Chinese consumers have two characteristics of insurance. The first is that trust is not enough. Because there are frauds, false sales, and product protection in the market, the user’s own trust in insurance is very low, especially for the sick. In other words, if you are already suffering from a certain type of disease, if you are promoted insurance related to certain diseases and protect certain types of low-probability events such as complications, it is difficult for users to believe in the necessity of insurance if they do not have certain knowledge of insurance.
The second is that Chinese consumers' perception of insurance is more important than consumption, that is, they are used when they are bought. This can be seen from the high-yield odds of reimbursement-type insurance products. On the one hand, like foreign insurance markets, the more people who are sick or the more they think they are unhealthy, the more they have the incentive to buy insurance, so they can use these insurances. On the other hand, the purchase of insurance will also encourage users to use more, especially for users who pay for insurance, the mentality of using the foot is very obvious, which will push up the excessive use of medical care. Therefore, in the insurance products of certain diseases such as diabetes, the guarantee is for complications, and the duration of diabetes is long, the users can not see the possibility of nearby consumption, and the mentality of the foot can not be satisfied, so they are convinced to purchase such protection. Extremely difficult.
Medicine raw materials is our company's main products, our company in China's shaanxi xi 'an not ended district, is a specialized in production of pharmaceutical raw materials research and development, production, sales for the integration of biological technology co., LTD., we have specialized in pharmaceutical raw materials production factories, professional qualifications, and professional production staff, in the process of pharmaceutical raw materials production, our innovative production technology, Strengthen scientific and technological innovation, invest professional production equipment, use high-tech equipment to extract medical raw materials in the process of medical raw materials production, have high quality human drug raw materials, more reasonable price.
The main products are:Human Apis,Dimethocaine Hydrochloride Powder,Sertraline Hydrochloride 100 Mg,Ciprofloxacin Lactate Powder
Human Apis,Dimethocaine Hydrochloride Powder,Sertraline Hydrochloride 100 Mg,Ciprofloxacin Lactate Powder
Xi'an Henrikang Biotech Co.,Ltd , https://www.xianhenrikangbio.com